Molecular Hydrogen Reverses Sepsis-induced Immunoparalysis: Insights from Longitudinal Deep Immunophenotyping.
Chang-Lung Wu, Jeng-Wei Lu, Yi-Jung Ho, Shan-Wen Lui, Ting-Yu Hsieh, Kuang-Yih Wang, Feng-Cheng Liu · In vivo (Athens, Greece) · 2026
Research-use notice
Independent study record
Each H2HUBB study page organizes source-linked research details for educational use. Interpretation should remain proportional to the study design, population, controls, and limitations.
H2HUBB TAKEAWAY
In this case report, adjunctive hydrogen inhalation was followed by temporary clinical stabilization and longitudinal immune changes in a 49-year-old man with refractory septic shock. The report described the patient's death from irreversible chronic comorbidities. This single case suggests possible immunomodulatory potential, while controlled clinical studies are needed to determine safety and effectiveness.
What Effects Did Molecular Hydrogen Have?
In this case report, adjunctive hydrogen inhalation was followed by temporary clinical stabilization and longitudinal immune changes in a 49-year-old man with refractory septic shock. However, longitudinal evidence on the effects of molecular hydrogen on deep human immunophenotyping remains scarce. At a therapeutic impasse marked by high levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) (>35,000 pg/ml) and profound immune depletion, adjuvant hydrogen inhalation was initiated, which led to a 64% reduction in myocardial stress and temporary clinical stabilization. In the T-cell compartment, hydrogen induced a biphasic resolution of exhaustion in T-helper cells marked by an immediate decline in expression of FAS cell surface death receptor (FAS; also known as CD95) and asynchronous normalization of expression of programmed cell death protein 1 (PD1) and T-cell immunoglobulin and mucin domain 3 (TIM3), alongside bidirectional restoration of physiological immune checkpoints in cytotoxic T-cells. The authors concluded that by disrupting the cycle of immune exhaustion and exerting anti-apoptotic effects, molecular hydrogen may represent a promising immunomodulatory adjunct in severe sepsis. Pathophysiologically, this radiographic improvement can be attributed to the protective effects of hydrogen on endothelial integrity, likely mediated through the NRF2/HO1 signaling pathway and newly identified targets such as APOA2 ( 14, 15 ).
What the Findings Mean
At a therapeutic impasse marked by high levels of N-terminal pro-B-type natriuretic peptide (NT-proBNP) (>35,000 pg/ml) and profound immune depletion, adjuvant hydrogen inhalation was initiated, which led to a 64% reduction in myocardial stress and temporary clinical stabilization.
Why These Findings Matter
These findings add human evidence supporting molecular hydrogen's therapeutic potential across the specific human outcomes evaluated in this study and contribute to the growing body of molecular-hydrogen research.
How Strong Is This Evidence?
This is human clinical evidence from a case report. H2HUBB interprets the findings in the context of the study design, sample, comparator, and measured outcomes rather than using one publication as a verdict on hydrogen therapy.
Technical Study Details
H2HUBB classifies this publication as case report with human clinical evidence.
Limitations and Safety
No separate limitations or safety findings were identified in the current-study source text available to H2HUBB. The report described the patient's death from irreversible chronic comorbidities. This single case suggests possible immunomodulatory potential, while controlled clinical studies are needed to determine safety and effectiveness.
Original Study and H2HUBB Research Context
H2HUBB presents this source-grounded research record as one contribution to the broader molecular-hydrogen evidence base.
What the Researchers Studied
The study was classified as case report.